At a glance
Two formulation studies provide human skin-measurement data. Each changes several ingredients and a delivery system together, preventing attribution to one peptide.
Identity & scope
SNAP-8 is associated with acetyl octapeptide-3 in the identity record used by the existing catalogue references. A supplier name alone is not analytical confirmation of material identity.
What the research shows
- The 2024 patch comparison reported improvements in selected wrinkle and skin measurements versus a hyaluronic-acid-only patch.
- An earlier single-centre study reported changes after a multi-active patch regimen.
Critical interpretation
The comparator determines what can be attributed
The 2024 experiment compares a formulation containing several actives with a hyaluronic-acid patch. It can test the package of ingredients and device together, but it has no arm removing only acetyl octapeptide-3. Attribution to that peptide or a claimed interaction therefore remains a hypothesis. The earlier multi-active study has the same ingredient-attribution problem. Two positive formulation reports do not become two independent demonstrations of isolated-peptide efficacy. [1] [2]
A delivery device is part of the tested intervention
A dissolving microneedle is designed to alter delivery through the skin barrier. Its results cannot establish what reaches tissue from a plain solution, conventional cosmetic, vial or nasal preparation. Instrumental skin measurements and short tolerability observation also answer narrower questions than lasting cosmetic benefit or long-term safety. Further research would need ingredient-specific comparisons, independently characterised formulations and follow-up beyond the short observation periods before a broad peptide claim could be justified. [1] [2]
Read participant flow alongside the headline
The later paper enrolled 24 people and analysed 21 completers. That is a small observation window with some attrition, not a broad assurance about everyone who might encounter the ingredient. A useful replication would preserve participant flow, prespecified endpoints and ingredient-specific comparisons alongside its headline result. [1]
Limitations & uncertainties
- Neither study isolates this ingredient's contribution, and the earlier study's abstract does not establish a randomised ingredient-specific comparison.
- Short-term cosmetic measurements cannot establish systemic safety, nasal bioavailability or comparable effects of another formulation.
Open research questions
- Would an independently run trial isolate the peptide's effect from the other ingredients and delivery device?
Selected papers & source records
Download bibliography1. Clinical Safety and Efficacy Evaluation of a Dissolving Microneedle Patch Having Dual Anti-Wrinkle Effects With Safe and Long-Term Activities (opens in a new tab)
Shin JY, Han D, Yoon KY, Jeong DH, Park YI (2024). Annals of Dermatology. DOI: 10.5021/ad.23.136 (opens in a new tab) · PMID 39082657
- Design & population
- Opposite-eye comparison of combination versus hyaluronic-acid-only microneedle patches over 28 days; 24 adults enrolled and 21 completed.
- What the study found
- Several skin and wrinkle endpoints favoured the combination; no adverse effects were reported during the short study.
- Limits on interpretation
- Multiple active ingredients, small sample and device-specific delivery. Several authors were affiliated with the patch company.
Original source (opens in a new tab) · Full text at publisher / archive (opens in a new tab)
2. Efficacy of bioactive peptides loaded on hyaluronic acid microneedle patches: A monocentric clinical study (opens in a new tab)
Avcil M, Akman G, Klokkers J, Jeong D, Çelik A (2020). Journal of Cosmetic Dermatology. DOI: 10.1111/jocd.13009 (opens in a new tab) · PMID 31134751
- Design & population
- Twelve-week single-centre study of a patch containing several peptides, adenosine and seaweed extracts.
- What the study found
- Authors reported improved wrinkle, hydration, density and thickness measurements and no reported skin reactions.
- Limits on interpretation
- A formulation result, not proof of isolated acetyl octapeptide-3 efficacy. Manufacturer-funded, with commercial affiliations.
Search & review scope
Targeted searches of the catalogue's primary reference and related acetyl-octapeptide microneedle studies.. Checked 9 November 2026.
Two human multi-ingredient formulation reports. Full-text 2024 methods, participant flow, results and discussion were checked at the journal; the earlier report remains abstract-reviewed.
Not a complete ingredient dossier or systematic search. Ingredient-containing trials do not validate supplier material; a comprehensive publication-status audit was not performed.
Recorded search terms
- 39082657 acetyl octapeptide microneedle
- Acetyl Octapeptide 31134751 authors
- Clinical Safety and Efficacy Evaluation Microneedle retracted
- Clinical Safety and Efficacy Evaluation 21 subjects Shin
- Clinical Safety and Efficacy Evaluation random 24 microneedle
Read the collection’s methods and editorial limits. For formal research, assess and cite the original paper.
Cite this review
HeartPep. Snap8 / acetyl octapeptide-3: literature review. HeartPep literature library. Reviewed 9 November 2026. https://heartpep.com/us/research/library/snap8.
HeartPep is the commercial publisher of this secondary summary. It is not a peer-reviewed primary paper. Cite the original studies for their findings.
Buy from HeartPep.com
Laboratory research only. Not for human or veterinary use.